Pascal Biosciences Inc. (PSCBF) Stock Analysis
DELISTED 2024
What happened to Pascal Biosciences Inc. (PSCBF) stock?
Pascal Biosciences Inc. (PSCBF) no longer trades on public markets. It was delisted in June 2024. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- June 2024
- Last recorded price (historical):
- $0.11 (last quote on record before the June 2024 delisting; historical, not a current quote)
Market cap $4.20M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Pascal Biosciences Inc. (PSCBF). Pascal Biosciences Inc. is a biotechnology company focused on developing therapies for cancer and immune system improvement. Their portfolio includes PAS-403 for glioblastoma and PAS-393, an immune-stimulatory cannabinoid for cancer treatment.
Last analyzed: Mar 16, 2026Dated analysis: the newest financial statements on file are 32 months old (Feb 1, 2024), so the figures and score below describe that period, not today.
Pascal Biosciences Inc. (PSCBF) Healthcare & Pipeline Overview
PSCBF OTC Market Information
PSCBF trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy PSCBF shares?
No. PSCBF stopped trading on public markets in June 2024, so the shares are not available through a broker. Anything you see quoted for PSCBF elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before PSCBF stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Pascal Biosciences Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.